According to Morningstar Equity Research, several other players, including Pfizer, Roche, Amgen AMGN, AstraZeneca AZN, Zealand Pharma ZLDPF, and Structure Therapeutics GPCR are expected to join in, with multiple drug launches anticipated between 2027 and 2032
Tirzepatide HypoSpray therapy is a prescription option that uses a needle-free transdermal spray format
El ensayo Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (El efecto y la accin de la liraglutida sobre la diabetes: una evaluacin de los resultados cardiovasculares, LEADER, por sus siglas en ingls) evalu el efecto del GLP-1 liraglutida, sobre la salud cardiovascular
Dietary Carbohydrate (Amount and Type) in the Prevention and Management of Diabetes: A statement by the American Diabetes Association